Although inhibition of mTOR with rapamycin reduces food intake and prevents fat-diet induced obesity in mice, rapamycin administration attenuates glucose uptake and metabolism in skeletal muscle through prevention of insulin generated Akt activation and alteration in the translocation of glucose transporters to the plasma membrane [95]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.